Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of SR46349B (1 and 5mg/Day) Administered During 8 Weeks in Patients With Sleep Disorders in Fibromyalgia: Multi-center, Randomized, Double-blind, Placebo-controlled Study.

NCT00313885 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00313885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00313885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of SR46349B (1 and 5mg/Day) Administered During 8 Weeks in Patients With Sleep Disorders in Fibromyalgia: Multi-center, Randomized, Double-blind, Placebo-controlled Study.
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2004
Completion date
June 30, 2005
Enrollment
205 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pain, fibromyalgia, sleep